
|Articles|March 1, 2002
PC-SPES not as beneficial for androgen-dependent PCa
New York-Some prostate cancer patients may be running to the healthfood store for supplements like PC-SPES, but the supplement cannot competewith other tried and true hormonal therapies, at least in men with androgen-dependentdisease, according to William Oh, MD.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
2
Farah Rahman, MD, on monitoring resident wellness using biofeedback
3
Pearls & Perspectives: Innovation and Evolving Pathways in Female Pelvic Medicine, with Raveen Syan, MD, FPMRS
4
Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing
5






